Evidence map›Paper›PMID 22109347›Full record

ArticleCancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology2011

HIV infection, immunodeficiency, viral replication, and the risk of cancer.

Michael J Silverberg, Chun Chao, Wendy A Leyden, Lanfang Xu, Michael A Horberg, Daniel Klein, William J Towner, Robert Dubrow, Charles P Quesenberry, Romain S Neugebauer and 1 more

Registry-linked trialOpen access · bronzeAbstract read
In one paragraph

Article in Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01671501 (Primary Care-Based Interventions to Reduce Alcohol Use Among HIV Patients), which is not on this map. Cited by 140 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
140citing papers in PubMed, 7 pooled it
11.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01671501 nacompletednot on this mapstarted 2013, after this paper: background citation

Primary Care-Based Interventions to Reduce Alcohol Use Among HIV Patients

TypeinterventionalSponsorUniversity of California, San FranciscoRan2013 to 2017Enrolled614ConditionsHIV, Acquired Immunodeficiency Syndrome, Alcoholism, Alcoholic IntoxicationArmsMotivational Interviewing, Email Feedback, Usual Care
3 · Its place in the literature

Who cites it

140 citing papers in PubMed, 7 syntheses or guidelines pooled it, 283 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. The association between the polymorphisms of TNF-α and non-Hodgkin lymphoma: a meta-analysis.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2014
    Pooled it
  6. Pooled it
  7. Pooled it
  8. Trial
  9. Immediate Antiretroviral Therapy Reduces Risk of Infection-Related Cancer During Early HIV Infection.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2016
    Trial
  10. Observational
  11. Article
  12. Review
  13. Clinical Predictors and Incidence of Kaposi Sarcoma Among Males With HIV in the Treat-All Era in the United States and Canada.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2026
    Article
  14. Article
  15. HIV-1 Viremia and Cancer Risk in 2.8 Million People: The South African HIV Cancer Match Study.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2025
    Article
  16. Article
  17. Review
  18. Article
  19. Prostate cancer in people with HIV.Current opinion in infectious diseases · 2025
    Review
  20. Review

80 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Michael J SilverbergKaiser Permanente Northern California, Oakland, CA 94612, USA. Michael.J.Silverberg@kp.org
Chun Chao
Wendy A Leyden
Lanfang Xu
Michael A Horberg
Daniel Klein
William J Towner
Robert Dubrow
Charles P Quesenberry
Romain S Neugebauer
Donald I Abrams
Kaiser Permanente · USUniversity of California, San Francisco · USSan Francisco General Hospital · US

Funding

Alcohol Associated Outcomes Among HIV+/- Aging VeteransU10AA013566 · NIAAA · YALE UNIVERSITY · PI JUSTICE, AMY CAROLINE · 2006 to 2010
$12.7M
HIV Infection, Antiretroviral Therapy, Cancer Incidence and ProgressionK01AI071725 · NIAID · KAISER FOUNDATION RESEARCH INSTITUTE · PI SILVERBERG, MICHAEL J · 2007 to 2011
$702k
NIAAA NIH HHS U10 AA013566NIAAA NIH HHS U10-AA13566NIAID NIH HHS K01 AI071725NIAID NIH HHS K01AI071725
6 · The paper itself

Abstract

backgroundFew studies have compared cancer risk between HIV-infected individuals and a demographically similar HIV-uninfected internal comparison group, adjusting for cancer risk factors.

methodsWe followed 20,775 HIV-infected and 215,158 HIV-uninfected individuals enrolled in Kaiser Permanente (KP) California for incident cancer from 1996 to 2008. Rate ratios (RR) were obtained from Poisson models comparing HIV-infected (overall and stratified by recent CD4 count and HIV RNA) with HIV-uninfected individuals, adjusted for age, sex, race/ethnicity, calendar period, KP region, smoking, alcohol/drug abuse, and overweight/obesity.

resultsWe observed elevated RRs for Kaposi sarcoma (KS; RR = 199; P < 0.001), non-Hodgkin lymphoma (NHL; RR = 15; P < 0.001), anal cancer (RR = 55; P < 0.001), Hodgkin lymphoma (HL; RR = 19; P < 0.001), melanoma (RR = 1.8; P = 0.001), and liver cancer (RR = 1.8; P = 0.013), a reduced RR for prostate cancer (RR = 0.8; P = 0.012), and no increased risk for oral cavity/pharynx (RR = 1.4; P = 0.14), lung (RR = 1.2; P = 0.15), or colorectal (RR = 0.9; P = 0.34) cancers. Lung and oral cavity/pharynx cancers were elevated for HIV-infected subjects in models adjusted only for demographics. KS, NHL, anal cancer, HL, and colorectal cancer had significant (P < 0.05) trends for increasing RRs with decreasing recent CD4. The RRs for lung and oral cavity/pharynx cancer were significantly elevated with CD4 < 200 cells/μL and for melanoma and liver cancer with CD4 < 500 cells/μL. Only KS and NHL were associated with HIV RNA.

conclusionImmunodeficiency was positively associated with all cancers examined except prostate cancer among HIV-infected compared with HIV-uninfected individuals, after adjustment for several cancer risk factors. IMPACT: Earlier antiretroviral therapy initiation to maintain high CD4 levels might reduce the burden of cancer in this population.

Indexed as

AdultAnti-HIV AgentsCohort StudiesFemaleHIV InfectionsHumansMaleNeoplasmsRisk FactorsViral LoadVirus ReplicationAnti-HIV Agents

Identifiers

PMID22109347
PMCPMC3237725
OpenAlexW2152200519

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.